These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29889862)

  • 1. Viral load testing and the use of test results for clinical decision making for HIV treatment in Cameroon: An insight into the clinic-laboratory interface.
    Awungafac G; Amin ET; Fualefac A; Takah NF; Agyingi LA; Nwobegahay J; Ondoa P; Njukeng PA
    PLoS One; 2018; 13(6):e0198686. PubMed ID: 29889862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
    Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
    BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
    Kadima J; Patterson E; Mburu M; Blat C; Nyanduko M; Bukusi EA; Cohen C; Oyaro P; Abuogi L
    PLoS One; 2018; 13(11):e0200242. PubMed ID: 30412576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of switch to paediatric second-line antiretroviral therapy after first-line failure in Cameroon.
    Njom-Nlend AE; Efouba N; Brunelle Sandie A; Fokam J
    Trop Med Int Health; 2021 Aug; 26(8):927-935. PubMed ID: 33905593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
    Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
    J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy.
    Kerschberger B; Boulle AM; Kranzer K; Hilderbrand K; Schomaker M; Coetzee D; Goemaere E; Van Cutsem G
    J Int AIDS Soc; 2015; 18(1):20092. PubMed ID: 26403636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges with targeted viral load testing for medical inpatients at Queen Elizabeth Central Hospital in Blantyre, Malawi.
    Craik A; Patel P; Patel P; Mallewa J; Malisita K; Bitilinyu-Bangoh J; van Oosterhout JJ; Kelly C
    Malawi Med J; 2016 Dec; 28(4):179-181. PubMed ID: 28321282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded access to viral load testing and use of second line regimens in Haiti: time trends from 2010-2017.
    Wang Y; Barnhart S; Francois K; Robin E; Kalou M; Perrin G; Hall L; Koama JB; Marinho E; Balan JG; Honoré JG; Puttkammer N
    BMC Infect Dis; 2020 Apr; 20(1):283. PubMed ID: 32299389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.
    Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Achieng B; Sepeka M; Tlali K; Sao L; Thin K; Klimkait T; Battegay M; Labhardt ND
    BMC Infect Dis; 2018 Feb; 18(1):76. PubMed ID: 29433430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The viral load monitoring cascade in a resource-limited setting: A prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho.
    Glass TR; Motaboli L; Nsakala B; Lerotholi M; Vanobberghen F; Amstutz A; Lejone TI; Muhairwe J; Klimkait T; Labhardt ND
    PLoS One; 2019; 14(8):e0220337. PubMed ID: 31461455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-site clinical evaluation of the Xpert(®) HIV-1 viral load assay.
    Jordan JA; Plantier JC; Templeton K; Wu AH
    J Clin Virol; 2016 Jul; 80():27-32. PubMed ID: 27135387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral load detection and management on first line ART in rural Rwanda.
    Ndagijimana Ntwali JD; Decroo T; Ribakare M; Kiromera A; Mugwaneza P; Nsanzimana S; Lynen L
    BMC Infect Dis; 2019 Jan; 19(1):8. PubMed ID: 30606128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Suboptimal Pediatric HIV Viral Load Cascade: Multidistrict Cohort Study Among Children Taking Antiretroviral Therapy in Lesotho, Southern Africa.
    Muhairwe JA; Brown JA; Motaboli L; Nsakala BL; Lerotholi M; Amstutz A; Klimkait T; Glass TR; Labhardt ND
    Pediatr Infect Dis J; 2022 Mar; 41(3):e75-e80. PubMed ID: 34862344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti.
    Jean Louis F; Buteau J; François K; Hulland E; Domerçant JW; Yang C; Boncy J; Burris R; Pelletier V; Wagar N; Deyde V; Lowrance DW; Charles M
    PLoS One; 2018; 13(1):e0192077. PubMed ID: 29381736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short communication: east meets west: a description of HIV-1 drug resistance mutation patterns of patients failing first line therapy in PEPFAR clinics from Uganda and Nigeria.
    Crawford KW; Wakabi S; Kibuuka H; Magala F; Keshinro B; Okoye I; Akintunde E; Hamm TE
    AIDS Res Hum Retroviruses; 2014 Aug; 30(8):796-9. PubMed ID: 24798614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of near point-of-care viral load implementation in public health facilities across seven countries in sub-Saharan Africa.
    Boeke CE; Joseph J; Atem C; Banda C; Coulibaly KD; Doi N; Gunda A; Kandulu J; Kiernan B; Kingwara L; Maokola W; Maparo T; Mbaye RN; Mtumbuka E; Mziray J; Ngugi C; Nkakulu J; Nzuobontane D; Okomo Assoumo MC; Peter T; Rioja MR; Sacks JA; Simbi R; Vojnov L; Khan SA
    J Int AIDS Soc; 2021 Jan; 24(1):e25663. PubMed ID: 33455081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief Report: Interferon-γ-Inducible Protein 10-A Potential Marker for Targeted Viral Load Monitoring of Antiretroviral Treatment?
    Reepalu A; Arimide DA; Balcha TT; Björkman P; Medstrand P
    J Acquir Immune Defic Syndr; 2020 Apr; 83(5):475-478. PubMed ID: 31917753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
    Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
    HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral load testing among women on 'option B+' in Mazowe, Zimbabwe: How well are we doing?
    Nyakura J; Shewade HD; Ade S; Mushavi A; Mukungunugwa SH; Chimwaza A; Owiti P; Senkoro M; Mugurungi O
    PLoS One; 2019; 14(12):e0225476. PubMed ID: 31794561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is There a Need for Viral Load Testing to Assess Treatment Failure in HIV-Infected Patients Who Are about to Change to Tenofovir-Based First-Line Antiretroviral Therapy? Programmatic Findings from Myanmar.
    Thiha N; Chinnakali P; Harries AD; Shwe M; Balathandan TP; Thein Than Tun S; Das M; Tin HH; Yi Y; Babin FX; Lwin TT; Clevenbergh PA
    PLoS One; 2016; 11(8):e0160616. PubMed ID: 27505228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.